Frameshift variation in the HMG-CoA reductase gene and unresponsiveness to cholesterol-lowering drugs in type 2 diabetes mellitus patients. [PDF]
Khaleqsefat E +4 more
europepmc +1 more source
HMGCR genetic variability in Parkinson's disease in a Spanish cohort: associations with lipid metabolism and early onset. [PDF]
Díaz-Belloso R +13 more
europepmc +1 more source
Inhibition by the fungicide fenpropimorph of cholesterol biosynthesis in 3T3 fibroblasts [PDF]
F Schuber +3 more
core +1 more source
Jianpi-Huogu Prescription Repairs Nontraumatic Osteonecrosis of the Femoral Head by Inhibiting NAMPT/STK11/HMGCR/ACAT1 Axis-Mediated Lipid Production. [PDF]
Li T +8 more
europepmc +1 more source
Genetic correlation between genes targeted by lipid-lowering drugs and venous thromboembolism: A drug-target Mendelian randomization study. [PDF]
Li M +7 more
europepmc +1 more source
Uso crônico e regular de estatina previne fibrilação atrial no pós-operatório de cirurgia cardíaca [PDF]
Kenji Nakiri +2 more
core +1 more source
Biological Effects of Calceolarioside A as a Natural Compound: Anti-Ovarian Cancer, Anti-Tyrosinase, and Anti-HMG-CoA Reductase Potentials with Molecular Docking and Dynamics Simulation Studies. [PDF]
Chen L, Han D, Gu C, Huang W.
europepmc +1 more source
Epiafzelechin, a Flavanol, Regulates Lipid Homeostasis Through Modulation of HMGCR, PCSK9, and PPAR-α: Mechanistic Insights and Therapeutic Implications. [PDF]
Alshammari SO +7 more
europepmc +1 more source
Potential antihyperlipidemic effects of myrcenol and curzerene in high-fat fed rats. [PDF]
Tahir S +9 more
europepmc +1 more source
Association of lipid-lowering drug targets with risk of cutaneous melanoma: a mendelian randomization study. [PDF]
Miao L, Miao T, Zhang Y, Hao J.
europepmc +1 more source

